Sumatriptan
Is It Right for You?
A complete guide to Sumatriptan — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Sumatriptan?
Sumatriptan is a selective serotonin 5-HT1B/1D receptor agonist — the prototype member of the triptan class of medications — developed specifically for the acute treatment of migraine attacks. It is available in multiple formulations: oral tablets (50 mg and 100 mg), nasal spray (10 mg and 20 mg per actuation), and subcutaneous injection (6 mg auto-injector), allowing clinicians and patients to select the most appropriate formulation based on the speed of onset required and the severity of associated nausea and vomiting.
Sumatriptan does not prevent migraines from occurring. It is taken at the onset of an attack to abort the headache, relieve nausea, and resolve the associated symptoms of photophobia (light sensitivity) and phonophobia (sound sensitivity). It is one of the most widely prescribed and extensively studied acute migraine treatments in the world and has been in clinical use since the early 1990s.
Migraine is a complex neurological disorder affecting approximately 1 in 7 people, characterised by moderate-to-severe, often unilateral, throbbing headaches typically lasting 4–72 hours, accompanied by nausea or vomiting and heightened sensitivity to light and sound. In approximately one-third of patients, headaches are preceded by an aura — transient, usually visual neurological symptoms.
Oral sumatriptan 50 mg is available without prescription in the UK (Imigran Recovery) for patients with a pre-existing migraine diagnosis. Higher doses and other formulations are prescription-only.
Prescription sumatriptan formulations are prescription-only medications in the UK.
What Conditions Is Sumatriptan Used For?
Sumatriptan is indicated for:
with or without aura, in adults with an established migraine diagnosis
acute treatment using the subcutaneous injection formulation (the oral and nasal formulations are not licensed for cluster headache)
Sumatriptan aborts or reduces an attack in progress. It has no preventative effect if taken between attacks. If you experience frequent migraines, speak to your clinician about preventative (prophylactic) treatments such as topiramate, propranolol, amitriptyline, or anti-CGRP antibodies.
How Does Sumatriptan Work?
The pathophysiology of migraine involves activation of the trigeminovascular system: trigeminal nerve fibres innervating intracranial blood vessels release vasoactive neuropeptides — notably calcitonin gene-related peptide (CGRP), substance P, and neurokinin A. These mediate vasodilation of meningeal and cerebral blood vessels, neurogenic inflammation of meningeal structures, and sensitisation of central pain pathways, producing the characteristic throbbing headache and associated symptoms.
Sumatriptan acts via two complementary mechanisms:
Cranial vasoconstriction — by binding to 5-HT1B receptors on meningeal and intracranial blood vessels, sumatriptan causes selective vasoconstriction of abnormally dilated cranial vessels, reversing a key component of the migraine cascade.
Inhibition of trigeminovascular neuropeptide release — by acting on 5-HT1D receptors on trigeminal nerve terminals (at both peripheral and central levels), sumatriptan inhibits the release of CGRP and other pain-mediating neuropeptides, suppressing neurogenic inflammation and reducing the transmission of pain signals to the brain.
Together, these mechanisms interrupt the migraine cascade at multiple points, producing rapid relief of headache, nausea, photophobia, and phonophobia in the majority of patients when treatment is initiated at the headache phase of an attack.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take sumatriptan as early as possible once the headache begins. Do not wait for the pain to become severe — early treatment during the headache phase (not during the aura, which precedes the headache) gives the best results.
For subcutaneous injection, use the auto-injector into the outer thigh or abdomen, following the instructions provided with the device.
For nasal spray, blow the nose gently before use. Tilt the head slightly forward, insert the nozzle into one nostril, and press the plunger to release the dose while breathing gently through the mouth.
Rest in a quiet, darkened environment after taking sumatriptan where possible — this reduces sensory stimulation and can enhance the medication's effectiveness.
Do not exceed recommended doses within 24 hours.
Avoid using sumatriptan on more than 10 days per month — see medication overuse headache warning below.
Side Effects of Sumatriptan
Sumatriptan is generally well tolerated at recommended doses. Many side effects are transient and related to its vasoconstrictive mechanism.
- Tingling, warmth, heaviness, or pressure sensations in the limbs, chest, jaw, or neck (usually transient and benign)
- Flushing
- Dizziness
- Nausea
- Fatigue or drowsiness
- Injection site pain, stinging, or redness (with subcutaneous formulation)
- Taste disturbance (nasal spray formulation)
- Myocardial infarction or serious cardiac arrhythmia — rare; persistent severe chest pain, breathlessness, or arm pain should be treated as a potential cardiac emergency.
- Stroke or transient ischaemic attack — facial droop, arm weakness, speech disturbance; rare but reported.
- Serotonin syndrome — agitation, confusion, rapid heart rate, fever, tremor; particularly if used alongside other serotonergic agents.
- Severe allergic reaction / anaphylaxis
- Hypertensive crisis — rare; particularly in patients with undiagnosed or poorly controlled hypertension.
Feelings of chest tightness, heaviness, or pressure following sumatriptan use are very common and are typically benign — usually arising from oesophageal smooth muscle effects or musculoskeletal causes. However, if chest symptoms are intense, prolonged, or accompanied by breathlessness, sweating, or arm pain, they must be treated as potentially cardiac and emergency services should be called.
Drug Interactions
Sumatriptan may interact with MAOIs, ergotamine, and other triptans. Always inform your clinician about all medications you are taking.
Significantly increase sumatriptan plasma levels and markedly elevate the risk of toxicity. Sumatriptan is contraindicated during MAOI use and for 2 weeks after stopping an irreversible MAOI.
Additive vasospastic effects; do not use sumatriptan within 24 hours of any ergot-containing preparation, and vice versa.
Do not take two different triptans within 24 hours; additive vasospasm risk.
Risk of serotonin syndrome; monitor for symptoms. Current guidance does not recommend routine avoidance, but awareness of serotonin syndrome symptoms is important.
Important Warnings
Sumatriptan must not be used in patients with ischaemic heart disease (angina, previous myocardial infarction), Prinzmetal's (vasospastic) angina, peripheral vascular disease, prior stroke or transient ischaemic attack, or uncontrolled hypertension. Its vasoconstrictive mechanism carries serious cardiovascular risk in these populations.
Using any acute headache medication — including sumatriptan — on more than 10 days per month can paradoxically cause chronic daily headache (medication overuse headache). This is a common and often unrecognised cause of worsening or increasingly frequent migraines. If you are using sumatriptan frequently, speak to your clinician about preventative migraine treatment. MOH requires gradual medication withdrawal under medical supervision.
Sumatriptan is contraindicated in patients with hemiplegic migraine or basilar artery migraine due to the risk of serious neurological complications from vasoconstriction in vulnerable vascular territories.
Sumatriptan should be used with particular caution in men over 40 years and postmenopausal women due to the higher prevalence of undiagnosed cardiovascular disease in these groups. A cardiovascular risk assessment before prescribing is prudent.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Sumatriptan FAQs
Take sumatriptan as early as possible once the headache pain begins. Do not take it during the aura phase if you experience one — evidence suggests it is not effective during the aura, and early intervention at headache onset consistently produces better outcomes than waiting for pain to escalate.
Response rates vary between patients and between triptans. If two well-timed doses across separate attacks have not been effective, speak to your clinician. You may benefit from a different triptan (almotriptan, rizatriptan, zolmitriptan), a different formulation, or a combination approach such as sumatriptan plus a naproxen. Complete non-response to one triptan does not predict failure with another
Yes — combining sumatriptan with a non-steroidal anti-inflammatory such as naproxen or ibuprofen at the onset of an attack is more effective than either drug alone and is recommended in current migraine guidelines. Avoid overusing NSAIDs as this also contributes to medication overuse headache.
If acute headache treatments — including sumatriptan, paracetamol, NSAIDs, or opioids — are used on more than 10 days per month, they can paradoxically cause the brain to become more sensitive to pain, resulting in more frequent headaches. To avoid MOH, limit acute medication to no more than 10 days per month and seek preventative migraine therapy if attacks are frequent.
No. Sumatriptan is specifically active in migraine and cluster headache pathways. It does not work for tension-type headaches and is not indicated for this purpose.
Yes — the combination is safe and commonly prescribed. Propranolol modestly increases sumatriptan exposure but this is not clinically significant at normal doses.